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Abstract: BACKGROUND The aim of this study was to evaluate the impact of transcatheter aortic valve
implantation (TAVI) on mitral valve geometry and function. METHODS Eighty-four patients underwent
TAVI. Forty-four (52%) patients received a balloon-expandable valve and 40 (48%) were implanted with
a self-expandable valve. All patients underwent three-dimensional-volumetric transesophageal echocar-
diography of the mitral valve before and immediately after TAVI. A dedicated software was used for
assisted semiautomatic measurement of mitral annular geometry. RESULTS During systole, the anterior
to posterior (AP) diameter was significantly reduced after the procedure (3.4 ± 0.5 cm vs 3.2 ± 0.5 cm;
P < .05). The mitral annular area (10.8 ± 2.8cm2 vs 9.9 ± 2.6cm2 ; P < .05) as well as the tenting
area (1.6 ± 0.7 cm2 vs 1.2 ± 0.6 cm2 ; P < .001) measured at mid-systole were reduced after TAVI.
Diastolic measures were similar. Patients treated with balloon-expandable valves showed a significantly
larger reduction in the AP diameter compared to self-expandable valves (-0.25 cm vs -0.11 cm; P < .05).
The reduction of the annular area was higher in the balloon-expandable group (-1.2 ± 1.59 vs -0.22 ±
1.41; P < .05). Grade of mitral regurgitation did improve or remained stable after TAVI. CONCLUSION
TAVI significantly impacts the mitral valve and mitral annular geometry and morphology. The choice of
the prosthesis (balloon- vs self-expandable) may be relevant for those changes.
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Background: The aim of this study was to evaluate the impact of transcatheter
aortic valve implantation (TAVI) on mitral valve geometry and function.
Methods: Eighty‐four patients underwent TAVI. Forty‐four (52%) patients received
a balloon‐expandable valve and 40 (48%) were implanted with a self‐expandable
valve. All patients underwent three‐dimensional‐volumetric transesophageal echo-
cardiography of the mitral valve before and immediately after TAVI. A dedicated
software was used for assisted semiautomatic measurement of mitral annular
geometry.
Results: During systole, the anterior to posterior (AP) diameter was significantly
reduced after the procedure (3.4 ± 0.5 cm vs 3.2 ± 0.5 cm; P < .05). The mitral annular
area (10.8 ± 2.8cm2 vs 9.9 ± 2.6cm2; P < .05) as well as the tenting area (1.6 ± 0.7 cm2
vs 1.2 ± 0.6 cm2; P < .001) measured at mid‐systole were reduced after TAVI. Dia-
stolic measures were similar. Patients treated with balloon‐expandable valves
showed a significantly larger reduction in the AP diameter compared to self‐
expandable valves (−0.25 cm vs −0.11 cm; P < .05). The reduction of the annular area
was higher in the balloon‐expandable group (−1.2 ± 1.59 vs −0.22 ± 1.41; P < .05).
Grade of mitral regurgitation did improve or remained stable after TAVI.
Conclusion: TAVI significantly impacts the mitral valve and mitral annular geometry
and morphology. The choice of the prosthesis (balloon‐ vs self‐expandable) may be
relevant for those changes.
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1 | INTRODUCTION
A relevant number of patients with severe aortic stenosis suffers from
functional mitral regurgitation (MR).1,2 Improvement in MR after aortic
valve interventions has been described.3,4 A common explanation for this
phenomenon is the reduced end‐systolic load and pressure immediately
after aortic valve replacement in patients with aortic stenosis and the
long‐term positive effects of reverse remodeling.5 Due to the proximity
of the aortic and mitral valve annulus, mechanical interactions affecting
the aortomitral curtain may also be relevant modifiers of this effect.
Changes in mitral annular geometry are known to affect the coaptation
area and thereby function of the valve.6 Changes in the degree of MR
may also depend on the changes in mitral annular geometry after
transcatheter aortic valve implantation (TAVI).5 While this has been
consistently described for patients undergoing conventional open surgi-
cal aortic valve replacement (SAVR),7,8 studies in TAVI populations have
shown contradictory results in this regard.9,10 The aim of this study was
to identify changes of the mitral annular geometry after TAVI procedures
and to describe their potential impact on functional changes of the mitral
valve using a dedicated software (4D MV‐ASSESSMENT; Tomtec Ima-
ging Systems GmbH, Unterschleissheim, Germany) for advanced four‐
dimensional (4D)‐image analysis of preinterventional and postinterven-
tional transesophageal echocardiography (TOE) of the mitral valve.
2 | METHODS
2.1 | Study population
This study was approved by the local ethics committee of the Charité—
Universitätsmedizin Berlin (EA4/095/18). From May 2015 to June 2017,
a total of 404 patients underwent an elective TAVI procedure at the
German Heart Center Berlin and were screened for this study. All
patients were prospectively enrolled in the TAVI database of the German
Heart Center Berlin. For the study, the database was screened for pa-
tients who had a three‐dimensional (3D)‐TOE before and after the in-
tervention. Data extraction and image analysis were performed in a
retrospective manner. All patients who had a TAVI procedure at the
German Heart Center Berlin and had preinterventional and post-
interventional 3D‐TOE of the mitral valve with sufficient imaging quality
and quantity were eligible for the study. Exclusion criteria were: previous
surgery on the aortic valve and interventions on the mitral valve, such as
ring annuloplasty and mitral valve replacement. Fourteen patients were
excluded due to previous procedures affecting the aortic valve or the MV
apparatus. In addition, 240 patients were not eligible due to lack of
complete preoperative or postoperative 3D‐TOE data or lack of sufficient
image quality. Additionally, 66 patients who underwent analgosedation
with local anesthesia were excluded due to consecutive missing TOE
examination. Hence, 84 patients were eligible for this study (Figure 1).
Around half of the patients had implantation of a balloon‐
expandable valve (Edwards SAPIEN 3; n = 44; 52%). All other patients
had implantation of a self‐expandable prosthesis, (Symetis ACURATE
Neo; n = 12; 14%), Boston Scientific LOTUS (n = 6; 7%), St Jude Medical
Portico (n = 8; 10%), Corevalve Evolut R (n = 11; 13%), Biotronik
BIOVALVE (n = 2; 2%), and Direct Flow Medical, Inc (n = 1; 1%). Other
comorbidities and baseline characteristics are shown in Table 1.
2.2 | TAVI procedure and echocardiographic
assessment
TOE was routinely performed in cases with TAVI under general an-
esthesia. Besides the assessment of the aortic valve, evaluation of the
mitral valve was performed during the standard TOE protocol. Imaging of
the mitral valve was done preoperatively and postoperatively. The ima-
ges were prospectively stored followed by image analysis at a later stage.
F IGURE 1 Screening process. TAVI,
transcatheter aortic valve implantation; TOE,
transesophageal echocardiography
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Four to six cardiac cycles were captured to generate high‐resolution
images with an average of 19 frames per cardiac cycle, which were then
used to reconstruct and measure the mitral annulus. Preoperative re-
cordings were assessed after induction of anesthesia right at the
beginning of the procedure before any manipulation of the heart. Post-
operative TOE was performed after the confirmation of the final valve
position and with the patient experiencing stable hemodynamics. All
3D‐TOE examinations were carried out by a senior anesthesiologist with
high expertise in TOE using either a Phillips EPIQ 7 (Philips Health
System, Bothell, WA) or a GE Vivid E9 (GE Healthcare, Wauwatosa, WI)
ultrasound system equipped with 3D‐capable ultrasound probes. To
evaluate the preprocedural and postprocedural degree of MR in-
traprocedural TOE recordings, as well as TTE recordings assessed during
the hospitalization before discharge were reviewed and classified as
none, mild, moderate, or severe (0‐3). The grading was performed by a
single investigator (DG) and reviewed by another investigator (SHS), who
retrospectively assessed all the available preoperative and postoperative
echocardiographic images. Grading was done according to the current
guideline definitions.11,12
2.3 | Postprocessing and measurement of annular
geometry
The TOMTEC ImageArena (TomTec Imaging Systems GmbH,
Unterschleißheim, Germany) software provides a “4D MV‐
Assessment” tool, which was used for the reconstruction of the mitral
valve annulus. The software allows for semiautomatic measurement
of a variety of static and dynamic parameters of the mitral annulus.
Required landmarks were determined under the following conditions
and order: (1) long‐axis view showing a mid‐systolic frame, (2) de-
termination of the first four annular landmarks—setting up the
anterior, posterior, anterolateral, and posteromedial boundaries of
the annulus, (3) alignment to the aortic valve, and (4) determination
of the coaptation point, and (5) a reference point on the aortic root.
All examinations in ImageArena were performed by a single in-
vestigator (DG). Previous studies have shown that this method of image
analysis needs to have high reliability regarding intraobserver and in-
terobserver, reproducibility.13 The tool was adapted by the user to track
the parameters during systole and diastole. Diastolic values of para-
meters that were rendered unusable were discarded (ie, tenting
parameters).
The examined parameters were: anterior to posterior diameter
(AP), anterolateral to posteromedial (ALPM) diameter, sphericity index
(AP diameter/ALPM diameter), nonplanar angle, circumference, the
annular area in 2D and 3D, annular height, tenting volume (during
systole), commissural diameter, posterior leaflet angle, tenting height
(during systole), tenting area (during systole), the angle from the mitral
annulus to the aortic annulus, annular displacement, and displacement
velocity. As an example, the assessment of AP diameter, pre‐ and post‐
TAVI, is shown in Figure 2 and in the online Supporting Information.
2.4 | Statistical analysis
Raw data from the ImageArena was exported and processed to allow
comparability of the measurements. To deal with varying frame
TABLE 1 Characteristics of the study population
N 84
Female, n (%) 30 (35.7)
Age, mean (SD) 79.00 (7.32)
BMI, mean (SD) 28.16 (6.13)
Procedure, n (%)
TAVI TA 20 (23.8)
TAVI TF 62 (73.8)
TAVI transaortic 1 (1.2)










Sapien 3 44 (52)
Comorbidities, n (%)
Peripheral artery disease 24 (29)
COPD 20 (24)
Diabetes 21 (25)







Atrial fibrillation 23 (27)
Echo characteristics
LVEF, mean (SD) 49.24 (14.39)
LVEDD, mean (SD) 47.41 (8.08)
MR ≥ 2, n (%) 16 (19)
Risk scores
EuroSCORE I, mean (SD) 10.78 (3.73)
Logistic EuroSCORE, mean (SD) 18.08 (12.15)
EuroSCORE II, mean (SD) 8.23 (8.61)
STS Score mortality, mean (SD) 6.85 (7.12)
Abbreviations: BMI, body mass index; COPD, chronic obstructive
pulmonary disease; LVEDD, left ventricular end‐diastolic diameter; LVEF,
left ventricular ejection fraction; MR, mitral regurgitation; N.N, no
information available; NYHA, New York Heart Association Functional
Classification; TA, transapical; TAVI, transcatheter aortic valve
implantation; TF, transfemoral.
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numbers per cycle, the data were transformed as briefly described:
The raw echocardiographic data consists of two variables per mea-
sured parameter, where x designates the time of measurement in
milliseconds from the start of the heart cycle and y designates the
actual measured value. Time x was scaled to a decimal range of zero
to one (Figure 3), so that the start of the systole corresponds to x = 0
and the end to x = 1. The same scaling was applied to diastolic
measurements. The start times of the cycles were defined by an
electrocardiography trigger‐point. The time standardized measure-
ments were interpolated via cubic spline at 80 equally spaced points
per cycle spanning the range 0 to 1 (Figure 3).
This approach results in 214 240 interpolated and comparable va-
lues at any point of time in the heart cycle. Baseline data was gathered
from the institutional TAVI database and by reviewing surgery reports.
The analysis was performed for systole and diastole, as well as for the
entire cardiac cycle. Subgroups were formed for the implanted pros-
thesis to compare changes of annular geometry in 44 balloon‐expanded
vs 40 self‐expanding valves. Data were presented as means with stan-
dard deviation for continuous variables. The Student t test was used to
compare means of continuous variables for paired groups. At a P value
of less than .05, results were rated significant. Statistical analyses were
performed using R 3.4.2 (R Development Core Team. R: A Language and
Environment for Statistical Computing11); data preparation, processing,
and plotting were supported by tidyverse packages.14
3 | RESULTS
3.1 | Changes of the mitral valve geometry before
and after TAVI
At mid‐systole, AP diameter was significantly reduced after the proce-
dure (3.42 ±0.50 cm vs 3.24 ±0.52 cm; P= .02), while the anterolateral‐
posteromedial (ALPM) diameter (3.77 ±0.48 cm vs 3.66 ± 0.46 cm;
P= .123) was not. Area of the mitral annulus at mid‐systole was sig-
nificantly smaller after TAVI (10.8 ± 2.83 cm2 vs 9.94 ± 2.64 cm2;
P= .044) and the angle between aortic and mitral annulus was sig-
nificantly less steep after the procedures (128.8 ± 14.09° vs
137.18 ±14.45°; P< .001). The sphericity index reduced significantly
(0.91 ±0.07 vs 0.88 ± 0.07; P= .032), as well as the annular height
(0.79 ±0.24 cm vs 0.64 ± 0.19 cm; P< .001). Annular displacement and
displacement velocity did not differ significantly before and after im-
plantation of the prosthesis during systole. Analysis at mid‐diastole re-
vealed similar observations (Table 2 and Figure 4; a table in the online
Supporting Information shows an overview of all measured parameters)
indicating that mitral valve geometry undergoes substantial changes after
TAVI procedures.
3.2 | Impact of balloon‐ vs self‐expandable valves
A larger reduction in AP diameter was seen in patients who under-
went TAVI with a balloon‐expandable valve compared to those im-
planted with a self‐expandable valve (−0.25 cm vs −0.11 cm; P < .05).
This observation was, however, only evident in mid‐systole while it
was not present in mid‐diastole. The reduction of the annular area
was significantly higher in the balloon‐expandable group
(−1.2 ± 1.59 cm2 vs −0.22 ± 1.41 cm2; P < .05). A similar reduction was
found during diastole (−1.23 ± 1.57 cm2 vs −0.39 ± 1.46 cm2; P < .05)
(Table 3 and Figure 5).
3.3 | Relevance for mitral valve function
Before TAVI, of the 84 patients, 2 had an MR of grade 3, 4 had an MR
of grade 2 to 3, 11 had an MR of grade 2, 3 had an MR of grade
F IGURE 2 Images from the mitral annular
assessment with the TomTec 4D Mitral Valve
assessment tool. A,B, Three‐dimensional
visualization of the mitral valve with the
measurement of the AP diameter
pretranscatheter aortic valve implantation
(TAVI; A) and after TAVI implantation (B). A1
to A3 and P1 to P3 are the parts of the
anterior and posterior mitral leaflets. C,D,
Automatic assessment of the area of the
mitral annulus (C) pre‐ and (D) post‐TAVI
implantation. A1 to A3 and P1 to P3 are the
parts of the anterior and posterior mitral
leaflet
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1 to 2, 49 had an MR of grade 1, 4 had an MR of grade 0 to 1, and 11
had no MR.
After the procedure, 2 of the 84 patients had an MR of a grade
more than 2 to 3, 5 had an MR of grade 2, 1 had an MR of grade 1 to
2, 52 had an MR of grade 1, 7 patients had an MR of grade 0 to 1, and
17 had no MR. The degree of MR decreased in 21 (25%) patients and
did not change in the remaining 63 cases. Worsening or newly oc-
curring MR was not observed (Figure 6).
4 | DISCUSSION
In this study, we could show that TAVI is associated with substantial
changes in mitral annular geometry as assessed by 4D‐
echocardiography and measured with a semiautomated software
tool. In contrast to the previous studies, which only examined systolic
changes,7‐10 the observed effects were observed throughout the
entire cardiac cycle; however, most of them did not differ sig-
nificantly when compared to systole and diastole.
We found different changes at the mitral valve geometry, de-
pending on the type of prosthesis implanted (balloon‐ vs self‐
expandable). Changes were more relevant in the patients who had
implantation of a balloon‐expandable valve.
Previous studies investigating the effects on surgical SAVR also
found significant changes in mitral valve geometry and function after
surgical implantation of aortic valve prostheses. Mahmood et al7,8
report in a single‐center cohort study with 35 patients a significant
reduction of mitral annular area, circumference, AP diameter, and
F IGURE 3 Transformation of raw
measurements (here, aortomitral angle) with
varying frame numbers into a standardized
timeline and interpolated by a cubic spline.
Upper row: raw data of one exemplary
variable with standard time frame from the
echo machine; middle line: same data set after
time‐scaling into an x‐axis from 0 to 1; bottom
row: interpolation via cubic spline at 80
equally spaced points per cycle spanning the
range 0 to 1 (in this example for presentation
purposes, we used 120 equally spaced points)
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anterolateral‐posteromedial diameter after implantation of mainly
tissue prostheses. The anterior annulus length was more reduced
indicating the mechanical pressure on the annulus. While the ALPM
diameter did not change in our observations, the effect was
comparable with regard to AP diameter, annular area, and cir-
cumference. As the vertical annular displacement did not show any
significant alteration in our study, the dynamic motion of the annulus
seemed to be not restricted after TAVI. In line with the study of
TABLE 2 Measurements of mitral geometry pre‐ and post‐TAVI compared for mid‐systole and ‐diastole
Systole Diastole
Parameter Pre Post P value Pre Post P value
AP diameter, cm 3.42 (0.50) 3.24 (0.52) .20 3.43 (0.48) 3.22 (0.50) .005
ALPM diameter, cm 3.77 (0.48) 3.66 (0.46) .123 3.77 (0.47) 3.65 (0.45) .082
Annulus area, cm2 10.80 (2.83) 9.94 (2.64) .044 10.79 (2.78) 9.85 (2.54) .024
Sphericity index 0.91 (0.07) 0.88 (0.07) .032 0.91 (0.07) 0.88 (0.08) .009
Aortomitral angle, ° 128.80 (14.09) 137.18 (14.45) <.001 129.34 (13.63) 134.57 (14.56) .017
Annular height, cm 0.79 (0.24) 0.64 (0.19) <.001 0.73 (0.23) 0.61 (0.18) <.001
Annular displacement, mm 2.71 (1.69) 3.15 (1.87) .110 2.11 (1.54) 1.95 (1.43) .479
Displacement velocity, mm/s 17.53 (10.83) 17.27 (9.32) .867 −4.87 (7.33) −5.42 (13.09) .734
Note: Values are given as means and standard deviation.
Abbreviations: ALPM, antrolateral‐posteromedial; AP, anteriorposterior.
F IGURE 4 Changes of mitral valve geometry before and after transcatheter aortic valve implantation for all patients visualized over the
whole heart cycle. A, Aortomitral angle (degree). B, AP diameter (cm); C, annulus area (cm2). D, annular height (cm); E, sphericity index (cm/cm)
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Mahmood et al7 on SAVR, also in our study, a less‐steep aortomitral
angle was detected after TAVI.
A study comparing the effects of TAVI and AVR on mitral annulus
geometry found significant effects for AVR, but noted no changes for
TAVI and, therefore, suggested that TAVI was a more physiological
approach.10 Investigations by Shibayama et al9 found that TAVI did not
affect the mitral valve annular 3D parameters, but did improve mitral
leaflet tethering. In contrast to both the reports, our study showed a
significant impact of TAVI on mitral annular geometry.
Many of the observed parameters such as AP diameter, annular
area, and tenting parameters are known to be increased in patients
with MR.15,16 Changes in those annular dimensions are likely to have
TABLE 3 Postprocedural differences in parameters (means [standard deviations]) of mitral geometry parameters compared for balloon‐ vs
self‐expandable valves
Systole Diastole
Parameter Balloon Self P value Balloon Self P value
AP diameter, cm −0.25 (0.32) −0.11 (0.31) .040 −0.27 (0.32) −0.15 (0.34) .108
ALPM diameter, cm −0.20 (0.29) −0.01 (0.28) .003 −0.20 (0.28) −0.03 (0.28) .008
Annulus area, cm2 −1.32 (1.68) −0.33 (1.46) .005 −1.33 (1.66) −0.47 (1.52) .016
Sphericity index −0.02 (0.07) −0.03 (0.07) .573 −0.03 (0.07) −0.03 (0.07) .563
Aortomitral angle, ° 9.94 (18.15) 6.53 (19.48) .409 6.87 (18.32) 3.36 (19.57) .398
Annular height, cm −0.15 (0.22) −0.14 (0.20) .916 −0.12 (0.23) −0.12 (0.20) .962
Annular displacement, mm 0.50 (1.72) 0.37 (1.67) .731 −0.11 (1.88) −0.21 (1.10) .767
Displacement velocity, mm/s 1.01 (12.15) −2.31 (11.06) .197 −1.52 (14.82) 0.55 (11.87) .486
Abbreviations: ALPM, antrolateral‐posteromedial; AP, anteriorposterior.
F IGURE 5 Changes of mitral geometry before and after transcatheter aortic valve implantation (TAVI) visualized over the whole heart cycle
for balloon‐expandable vs self‐expandable valves. A, AP diameter (cm); B, annulus area (cm2); C, annular height (cm); D, sphericity Index (cm/cm)
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an impact on the coaptation of the mitral leaflets. Vergnat et al10
demonstrated the severity of MR to have a significant impact on
survival after TAVI and to decrease in grade after the procedure for a
majority of patients. Our results are in line with these findings as a
substantial part of our patients (25%) also showed a reduced grade of
MR after TAVI. A meta‐analysis by Nombela‐Franco et al17 observed
a greater improvement of MR in patients treated with a balloon‐
expanded prosthesis. Although in our study, the geometric changes in
the group of balloon‐expanded valves were more pronounced, there
was no evidence for the influence on improved MR in that group.
While the ALPM diameter did not change significantly, the reduction
of the AP diameter could be a surrogate for a mechanical component
as an explanation for the observed changes, conceivable directly
through the stent framework of the prosthesis pressing against the
anterior mitral annulus. This hypothesis is further supported by the
fact that significant differences were found between the groups of
self‐expanding vs balloon‐expanded valves with a higher effect evi-
dent from balloon‐expanded prostheses. However, hemodynamic
changes due to the eliminated aortic stenosis such as afterload re-
duction may certainly also play a role.18,19 Hence, we found possible
causative factors for the observed changes, which still need to be
validated in a larger patient cohort.
5 | LIMITATIONS
Our study was a single‐center cohort study in which the collected
data were retrospectively analyzed. Mitral calcification might
affect the annular geometry but was not assessed in our study
due to the assumption that calcifications affect the quality of
imaging. Another aspect that most likely has an influence on
mitral valve function and dynamics is the use of general an-
esthesia in all cases, but this might be less relevant because as a
bias it equally affects all study patients. However, the exact in-
fluence of general anesthesia on mitral annular geometry is un-
known. An approach through the apex for TAVI might impact the
left ventricular geometry. The inclusion of transapical ap-
proaches, therefore, might bias the subgroup analysis for balloon‐
expandable valves because implantation of Edwards SAPIEN 3
prostheses is mandatory in those cases. The self‐expandable
group shows a certain heterogeneity with regard to the implant
used. Due to different stent characteristics in various self‐
expandable prostheses, different effects on the mitral annulus
would be possible. Heart rhythm during the (TOE) was not ex-
amined. A possible presence of post‐implant pacing might cause
an asynchrony and also affect the mitral dynamics. TOMTEC
Imaging Systems provides its MV‐ASSESSMENT tool only for
systolic analysis of the mitral valve anatomy. We did also perform
a diastolic analysis of annular dimensions, so that the validity of
certain diastolic values may have potentially impacted the ana-
lysis to some extent. Therefore, diastolic parameters based on
the mitral valve leaflets being closed (tenting area, tenting vo-
lume, and tenting height) were discarded. Since our measure-
ments were only collected directly before and after the
procedure, we cannot exclude that the results observed are
short‐term effects. Thus, subsequent long‐term investigations,
including a TOE follow‐up examination, would be valuable but
were beyond the scope of this study.
F IGURE 6 Echocardiographic grade of mitral regurgitation (MR) before (left side) and after (right side) individually visualized transcatheter
aortic valve implantation for each patient
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6 | CONCLUSIONS
This study demonstrates that mitral valve anatomy and geometry is
significantly influenced by TAVI procedures. This is even more pro-
nounced for balloon‐expandable valves and, thus, may be relevant for
planning procedures and prosthesis selection. Grade of MR improved
or was unchanged, which may also be attributed to the relevant
geometric changes of the annulus in addition to the established
mechanism of afterload reduction. To further assess the clinical re-
levance of these findings, further investigation in larger cohorts in-
cluding a long‐term follow‐up is warranted. The use of magnetic
resonance imaging for assessing mitral annular geometry could also
provide additional information.
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